Metabolic abnormalities in hyperoxia-induced lung diseases of neonates

doi:10.16352/j.issn.1001-6325.2024.07.1034

Abstract

Abstract: High oxygen(hyperoxia) concentration may damage multiple organs and systems in newborns, such as the lung, brain and intestines. Metabolic abnormalities are important early events in the pathogenesis of neonatal hyperoxia related pulmonary diseases. This article reviews the increased glucose and lipid metabolism as well as dys-regulation of amino acid metabolism after hyperoxia related bronchopulmonary dysplasia in newborns. The potential mechanism may be that the high oxygen concentration increases formation of mitochondrial reactive oxygen species (mtROS), and also change the mitochondrial dynamics of neonatal bronchopulmonary dysplasia, leading to reduction of mitochondrial fusion, enhances fission and autophagy. This study also finds that many metabolism-related enzymes and metabolites are changed during hyperoxia related diseases. However, clinical research has not yet been conducted. Future research should focus on combining metabolic profiles with multi omics data, including transcriptome sequencing, genomics and proteomics to identify potential biomarkers and therapeutic targets for hyperoxia related neonatal lung injury in order to develop new strategies for the treatment of metabolic abnormalities resulted from neonatal hyperoxia related pulmonary diseases.

Key words: newborn, hyperoxia, lung disease, metabolic abnormalities, mitochondria

CLC Number:

R722.19

HE Guangliang, WANG Tao, LIU Lei, ZHOU Jian, YE Min. Metabolic abnormalities in hyperoxia-induced lung diseases of neonates[J]. Basic & Clinical Medicine, 2024, 44(7): 1034-1038.

References

[1]Brancaccio M, Mennitti C, Cesaro A, et al. The biological role of vitamins in athletes′ muscle, heart and microbiota[J]. Int J Environ Res Public Health, 2022, 19: 1249. doi: 10.3390/ijerph19031249.
[2]Chen F, Li Z, Xu Y, et al. Non-targeted metabolomic study of fetal growth restriction[J]. Metabolites, 2023, 13: 761. doi: 10.3390/metabo13060761.
[3]Zhao X, Wang L, Lin H, et al. Inhibition of MAT2A-related methionine metabolism enhances the efficacy of cisplatin on cisplatin-resistant cells in lung cancer[J]. Cell J, 2022, 24: 204-211.
[4]Gong J, Feng Z, Peterson AL, et al. The pentose phosphate pathway mediates hyperoxia-induced lung vascular dysgenesis and alveolar simplification in neonates[J]. JCI Insight, 2021, 6: e137594. doi: 10.1172/jci.insight.
[5]Yue L, Lu X, Dennery PA, et al. Metabolic dysregula-tion in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches[J]. Redox Biol, 2021, 48: 102-104.
[6]El-Hattab MY, Nagumo Y, Gourronc FA, et al. Human adipocyte conditioned medium promotes in vitro fibroblast conversion to myofibroblasts[J]. Sci Rep, 2020, 10: 10286. doi: 10.1038/s41598-020-67175-3.
[7]Huang LT, Chou HC, Chen CM. Inhibition of FABP4 attenuates hyperoxia-induced lung injury and fibrosis via inhibiting TGF-β signaling in neonatal rats[J]. J Cell Physiol, 2022, 237: 1509-1520.
[8]Thomas JM, Sudhadevi T, Basa P, et al. The role of sphingolipid signaling in oxidative lung injury and pathogenesis of bronchopulmonary dysplasia[J]. Int J Mol Sci, 2022, 23: 1254. doi: 10.3390/ijms23031254.
[9]Zhu Y, Mi L, Lu H, et al. ILC2 regulates hyperoxia-induced lung injury via an enhanced Th17 cell response in the BPD mouse model[J]. BMC Pulm Med, 2023, 23: 188. doi: 10.1186/s12890-023-02474-9.
[10]Zhang L, Wang P, Shen Y, et al. Mechanism of lncRNA H19 in regulating pulmonary injury in hyperoxia-induced bronchopulmonary dysplasia newborn mice[J]. Am J Perinatol, 2022, 39: 1089-1096.
[11]Bezerra FS, Lanzetti M, Nesi RT, et al. Oxidative stress and inflammation in acute and chronic lung injuries[J]. Antioxidants (Basel), 2023, 12: 548. doi: 10.3390/antiox12030548.
[12]Chenna S, Koopman WJH, Prehn JHM, et al. Mechani-sms and mathematical modeling of ROS production by the mitochondrial electron transport chain[J]. Am J Physiol Cell Physiol, 2022, 323: C69-c83.
[13]Ma L, Wang Y, Li X, et al. Tom70-regulated mitochondrial biogenesis via TFAM improves hypoxia-induced dysfunction of pulmonary vascular endothelial cells and alleviates hypoxic pulmonary hypertension[J]. Respir Res, 2023, 24: 310. doi: 10.1186/s12931-023-02631-y.
[14]Ji L, Shen W, Zhang F, et al. Worenine reverses the Warburg effect and inhibits colon cancer cell growth by negatively regulating HIF-1α[J]. Cell Mol Biol Lett, 2021, 26: 19. doi: 10.1186/s11658-021-00263-y.
[15]Miyano K, Okamoto S, Yamauchi A, et al. The downregulation of NADPH oxidase Nox4 during hypoxia in hemangioendothelioma cells: a possible role of p22(phox) on Nox4 protein stability[J]. Free Radic Res, 2021, 55: 996-1004.
[16]Freeman AE, Willis KA, Qiao L, et al. Microbial-induced redox imbalance in the neonatal lung is ameliora-ted by live biotherapeutics[J]. Am J Respir Cell Mol Biol, 2023, 68: 267-278.
[17]季玮, 朱玥, 尧惠慈, et al. 白三烯C4及2型固有淋巴细胞在支气管肺发育不良中的变化及意义[J]. 基础医学与临床, 2023, 43: 711-716.
[18]Tian X, Zhang Q, Huang Y, et al. Endothelin-1 downregulates sulfur dioxide/aspartate aminotransferase pathway via reactive oxygen species to promote the proliferation and migration of vascular Smooth muscle cells[J]. Oxid Med Cell Longev, 2020, 2020: 9367673. doi: 10.1155/2020/9367673.
[19]Chen L, Shi C, Zhou G, et al. Genome-wide exploration of a pyroptosis-related gene module along with immune cell infiltration patterns in bronchopulmonary dysplasia[J]. Front Genet, 2022, 13: 1074723. doi: 10.3389/fgene.2022.1074723.
[20]Jiang J, Wang J, Li C, et al. Hyperoxia induces alveolar epithelial cell apoptosis by regulating mitochondrial function through small mothers against decapentaplegic 3 (SMAD3) and extracellular signal-regulated kinase 1/2 (ERK1/2)[J]. Bioengineered, 2022, 13: 242-252.
[21]Zhang S, Wang Y, Cao Y, et al. Inhibition of the PINK1-Parkin pathway enhances the lethality of sorafenib and regorafenib in hepatocellular carcinoma[J]. Front Pharmacol, 2022, 13: 851832. doi: 10.3389/fphar.2022.851832.
[22]Song W, Wu X, Wang S, et al. Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma[J]. Transl Lung Cancer Res, 2023, 12: 2476-2493.
[23]Dai Y, Yu B, Ai D, et al. Mitochondrial fission-mediated lung development in newborn rats with hyperoxia-induced bronchopulmonary dysplasia with pulmonary hypertension[J]. Front Pediatr, 2020, 8: 619853. doi: 10.3389/fped.2020.619853.
[24]Wu D, Yang Y, Hou Y, et al. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of sirtuin 1[J]. Cancer Commun (Lond), 2022, 42: 37-55.
[25]秦玉春, 邝向东, 蔡林再, et al. 双氢青蒿素减轻慢性阻塞性肺疾病(COPD)模型大鼠肺损伤[J]. 基础医学与临床, 2023, 43: 427-432.